A tropomyosin point mutant recapitulates the <i>rng8/9</i> deletion phenotype. by Omaya Dudin (3926825)

“…(F) Quantifications of the number of Myo52-tdTomato dots observed in <i>cdc8</i>^<i>E104A</i> <i>and cdc8</i>^<i>E104A</i> <i>myo51</i>Δ mutants in comparison to wildtype (N>100 cells). …”

Sample selection flowchart. by Ronald López (18098572)

Subjects:

Inhibition of ATM kinase activity decreases H3K36me3 on the HPV31 genome and alters processing of late viral RNAs. by Dipendra Gautam (3215988)

Trends in prevalence of stunting, underweight, and wasting among children under five in Ethiopia by survey year. by Frehiwot Birhanu (17507395)

Subjects:

<i>clec-4(ok2050)</i> and <i>clec-4(ya1)</i> decrease <i>C</i>. <i>elegans</i> feeding leading to a reduced bacterial load. by Barbara Pees (3313560)

Descriptive statistics (mean [standard deviation] or % [sample size]) for study variables analyzed in the current study. by Angelina R. Sutin (9216456)

Genes whose expression was decreased in RASMC subjected to Na⁺,K⁺-ATPase inhibition. by Svetlana V. Koltsova (321381)

“…Given <i>in italics</i> are genes whose differential expression was detected in ischemic tissue by whole genome microarray-based analysis <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Mazzatti1" target="_blank">[12]</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110597#pone.0110597-Leonard1" target="_blank">[18]</a>. …”

The sensitivity analysis results for standardized mean differences of circulating apelin levels between cases with CVDs and controls. by Hamed Akbari (8119361)

Subjects:

Mean change in pain severity and interference from baseline to 8 weeks. by Judith I. Tsui (5983160)

Subjects:

Overall evaluation of seven models tested to represent the relationship between maximum horizontal moving speed (<i>HSpeed</i>; <i>y</i>) and time duration of movement (<i>t</i><su... by Kai Roecker (847195)

Subjects:

Minutes of game participation, total and relative running distances grouped by team. by Kai Roecker (847195)

Subjects:

Graphical description of the fitting parameters. by Kai Roecker (847195)

Subjects:

Groups of power-profile curve fittings. by Kai Roecker (847195)

Subjects:

Players' positions. by Kai Roecker (847195)

Subjects:

<i>HSpeed</i> results overview. by Kai Roecker (847195)

Subjects:

Independence of the lower against the upper asymptotes. by Kai Roecker (847195)

Subjects:

mAP0.5 Curves of various models. by Yaojun Zhang (389482)

Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A₁ ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in th... by Shouping Wang (402959)

“…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A₁ AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A₁ ARs. …”

Schematic overview of the experimental setup using the Seraph^® 100 Microbind^® Affinity blood adsorber. by Malin-Theres Seffer (14808772)

Differences in mean scores of upper extremity performance in all five accelerometer-derived variables across four time points- pre-HABIT, post-HABIT, 3-month, and 6-month post-HABI... by Shailesh S. Gardas (20490020)